Page last updated: 2024-09-02

ramosetron and fluvoxamine

ramosetron has been researched along with fluvoxamine in 1 studies

Compound Research Comparison

Studies
(ramosetron)
Trials
(ramosetron)
Recent Studies (post-2010)
(ramosetron)
Studies
(fluvoxamine)
Trials
(fluvoxamine)
Recent Studies (post-2010) (fluvoxamine)
19494832,051518434

Protein Interaction Comparison

ProteinTaxonomyramosetron (IC50)fluvoxamine (IC50)
DRattus norvegicus (Norway rat)0.54
D(3) dopamine receptorRattus norvegicus (Norway rat)0.54
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.54
D(4) dopamine receptorRattus norvegicus (Norway rat)0.54
Sodium-dependent serotonin transporterHomo sapiens (human)0.0038
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.54
D(2) dopamine receptorRattus norvegicus (Norway rat)0.54
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)3.1
TransporterRattus norvegicus (Norway rat)0.54

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
den Adel, M; Kadokura, T; Krauwinkel, WJ; Nishida, A; Takeshige, T1

Other Studies

1 other study(ies) available for ramosetron and fluvoxamine

ArticleYear
The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects.
    European journal of clinical pharmacology, 2008, Volume: 64, Issue:7

    Topics: Adult; Area Under Curve; Benzimidazoles; Cross-Over Studies; Drug Interactions; Female; Fluvoxamine; Half-Life; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Quality of Life; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists

2008